← FDA Drug Approvals (Drugs@FDA)

TERIPARATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2023-11-16

Drug application

FDA Application #

ANDA208569

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERIPARATIDE

Generic name

TERIPARATIDE

Active ingredients

TERIPARATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2023-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown